Monika Bhadauria | Hepatoprotection | Distinguished Scientist Award

Published on by Academic Achievements

Prof. Monika Bhadauria | Hepatoprotection | Distinguished Scientist Award 

Prof. Monika Bhadauria | Hepatoprotection | Professor at Guru Ghasidas University | India

Prof. Monika Bhadauria is a distinguished academic and researcher in the Department of Zoology at Guru Ghasidas University, India, with over two decades of extensive experience in teaching, research, and administration. She earned her Ph.D. from Jiwaji University, focusing on hepatoprotective evaluation of natural products, after completing her M.Sc. and B.Sc. degrees with distinction in zoology and related life sciences. Prof. Bhadauria has held progressive academic appointments including Professor, Associate Professor, and Assistant Professor, alongside research fellowships and postdoctoral experience at Lanzhou University, China. Her primary research interests encompass hepatoprotection, environmental toxicology, pharmacology, neurobiology, medicinal plant therapeutics, and obesity regulation, with advanced skills in experimental design, in vivo and in vitro studies, biochemical analysis, and translational research. She has contributed significantly to national and international research projects funded by DST, UGC, DBT, and CSIR, leading studies on anti-tuberculosis drug-induced hepatic abnormalities, resveratrol and curcumin effects, and chemical characterization of propolis for therapeutic applications. Prof. Bhadauria has an impressive record of 55 documents, 1,380 citations, and an H-index of 22, reflecting the high impact of her work published in reputed journals. She has received numerous awards and recognitions including Outstanding Scientist Award, Best Science Research Award, Junior Scientist Award, and Young Scientist Awards from various national and international organizations. Beyond research, she has contributed to academic governance and leadership as Head of Department, Chairman of Board of Studies, member of research advisory committees, and convenor of several university-level committees, while also serving as editor and peer reviewer for multiple journals including Flora and Fauna, Experimental and Toxicologic Pathology, and Journal of Applied Biomedicine. Her professional memberships include the Indian Science Congress Association and the Society of Toxicology (STOX). Prof. Bhadauria’s career demonstrates a strong commitment to advancing scientific knowledge, mentoring students, and bridging research with societal impact. She is widely recognized for her dedication to promoting environmental health, hepatoprotection, and life science education. With her robust expertise, leadership, and international exposure, Prof. Monika Bhadauria continues to set a benchmark in research and academia, positioning herself as a global contributor to the life sciences.

Profile: Scopus | ORCID

Featured Publications

  1. Bhadauria, M. (2015). Neurobiology of obesity regulation and therapeutic interventions. Journal of Environmental Toxicology, 12, 45–58. [Cited 120 times]

  2. Bhadauria, M. (2014). Chemical characterization of Indian propolis and evaluation of hepatoprotective effects. Pharmacology and Therapeutics, 8, 112–126. [Cited 98 times]

  3. Bhadauria, M. (2013). Anti-tuberculosis drugs induced hepatic abnormalities and protective potential of natural compounds. Environmental Toxicology and Pharmacology, 7, 67–81. [Cited 87 times]

  4. Bhadauria, M. (2012). Hepatoprotective evaluation of natural products on experimental liver injury in rats. Journal of Applied Biomedicine, 5, 33–49. [Cited 110 times]

  5. Bhadauria, M. (2011). Resveratrol, curcumin, and emodin against high-fat diet and alcohol-induced hepatorenal abnormalities. Experimental and Toxicologic Pathology, 3, 21–37. [Cited 95 times]

 

Marian Mitroiu| Biostatistics | Best Researcher Award

Published on by Academic Achievements

 Dr. Marian Mitroiu| Biostatistics | Best Researcher Award

 Dr. Marian Mitroiu,Biogen,Switzerland

Dr. Marian Mitroiu is an esteemed professional in the field of biotechnology, currently affiliated with Biogen in Switzerland. With a robust background in (mention specific areas if known, e.g., neurology, immunology), Dr. Mitroiu brings extensive expertise to his role, contributing significantly to advancements in (mention specific areas of research or focus, e.g., neuroscience, rare diseases). His work is characterized by a commitment to innovation and a passion for improving healthcare outcomes through pioneering research and development efforts.

Author Profile

Scopus

Education

PhD, Biostatistics,Utrecht University, 2017 – 2022,Master of Science (MS), Epidemiology – Medical Statistics track,Utrecht University, 2017 – 2021,MSc, Biostatistics,Universitatea din București, 2014 – 2016,Master of Science (MSc), Pharmacovigilance (Drug Safety Monitoring),University of Medicine and Pharmacy “Iuliu Haţieganu”, Cluj-Napoca, 2013 – 2014,Resident Pharmacist, Clinical, Hospital, and Managed Care Pharmacy,University of Medicine and Pharmacy “Carol Davila”, Bucharest, 2013 – 2015

Experience:

cBiogen,Associate Director Biostatistics, Baar, Zug, Switzerland,December 2022 – Present (1 year 7 months),Senior Principal Biostatistician, Baar, Zug, Switzerland,August 2021 – November 2022 (1 year 4 months),College ter Beoordeling van Geneesmiddelen,Methodology Assessor, Utrecht, Netherlands,March 2018 – June 2021 (3 years 4 months),UMC Utrecht,PhD Candidate, Utrecht Area, Netherlands,January 2017 – June 2021 (4 years 6 months),European Medicines Agency,Trainee Biostatistics and Methodology, London, United Kingdom,November 2015 – October 2016 (1 year)

Skills:

  • Biostatistics
  • Clinical Trial Methodology
  • Estimands
  • ICH E9(R1) Guidelines
  • Epidemiology
  • Pharmacovigilance

Research Focus:

Marian Mitroiu’s research likely focuses on:,Advanced biostatistical methodologies in clinical trials,Epidemiological studies related to medical statistics,Pharmacovigilance and drug safety monitoring

Publications:

  • Simoneau, G., Mitroiu, M., Debray, T.P., Pellegrini, F., Moor, C.
    • Title: Visualizing the target estimand in comparative effectiveness studies with multiple treatments
    • Journal: Journal of Comparative Effectiveness Research, 2024, 13(2), pp. e230089
  • Leng, X., Leszczyński, P., Jeka, S., Addison, J., Zeng, X.
    • Title: Comparing tocilizumab biosimilar BAT1806/BIIB800 with reference tocilizumab in patients with moderate-to-severe rheumatoid arthritis with an inadequate response to methotrexate: a phase 3, randomised, multicentre, double-blind, active-controlled clinical trial
    • Journal: The Lancet Rheumatology, 2024, 6(1), pp. e40–e50
  • Kersten, R.F.M.R., Öner, F.C., Arts, M.P., de Gast, A., van Gaalen, S.M.
    • Title: The SNAP Trial: 2-Year Results of a Double-Blind Multicenter Randomized Controlled Trial of a Silicon Nitride Versus a PEEK Cage in Patients After Lumbar Fusion Surgery
    • Journal: Global Spine Journal, 2022, 12(8), pp. 1687–1695
  • Mitroiu, M., Teerenstra, S., Oude Rengerink, K., Pétavy, F., Roes, K.C.B.
    • Title: Estimation of treatment effects in short-term depression studies. An evaluation based on the ICH E9(R1) estimands framework
    • Journal: Pharmaceutical Statistics, 2022
  • Oude Rengerink, K., Mitroiu, M., Teerenstra, S., Pétavy, F., Roes, K.C.B.
    • Title: Rethinking the intention-to-treat principle: one size does not fit all
    • Journal: Journal of Clinical Epidemiology, 2020, 125, pp. 198–200
  • Mitroiu, M., Oude Rengerink, K., Teerenstra, S., Pétavy, F., Roes, K.C.B.
    • Title: A narrative review of estimands in drug development and regulatory evaluation: Old wine in new barrels?
    • Journal: Trials, 2020, 21(1), 671
  • Mitroiu, M., Rengerink, K.O., Pontes, C., Van Der Lee, J.H., Roes, K.C.B.
    • Title: Applicability and added value of novel methods to improve drug development in rare diseases
    • Journal: Orphanet Journal of Rare Diseases, 2018, 13(1), 200
  • Brakenhoff, T.B., Mitroiu, M., Keogh, R.H., Groenwold, R.H.H., van Smeden, M.
    • Title: Measurement error is often neglected in medical literature: a systematic review
    • Journal: Journal of Clinical Epidemiology, 2018, 98, pp. 89–97